Sleep

Dr Ian Neeland Describes Physiologic Effects of SGLT2 Inhibitors on Sleep Apnea

November 26th 2021, 6:00pm

Video

Ian J. Neeland, MD, FACC, FAHA, is co-director of the Center for Integrated and Novel Approaches in Vascular-Metabolic Disease for University Hospitals Harrington Heart & Vascular Institute and director of the UH Center for Cardiovascular Prevention, in the Cleveland, Ohio, area. Here, he explains how sodium-glucose co-transporter 2 (SGLT2) inhibitors can treat metabolic physiologic effects of sleep apnea.

Risk of Severe COVID-19 Heightened in Patients With Obstructive Sleep Apnea

November 24th 2021, 9:30pm

Article

In Icelandic patients, obstructive sleep apnea were associated with a 2-fold increased risk of severe COVID-19 that required hospitalization or led to death after accounting for obesity and other comorbidities.

Dr Daniel Greer on Emergence of CBT as First-line Treatment for Chronic Insomnia

November 20th 2021, 3:00pm

Video

Daniel Greer, PharmD, BCPP, clinical assistant professor, Rutgers Ernest Mario School of Pharmacy, discusses the use of cognitive behavioral therapy (CBT) as a first-line treatment for chronic insomnia and barriers limiting its use.

Asthma Diagnosis May Increase Risk of Narcolepsy

November 18th 2021, 6:15pm

Article

Patients with asthma were found to have a more than 3-fold greater risk of developing narcolepsy than those without asthma, with use of inhaled corticosteroids indicated to decrease risk.

CVS Health’s Theresa Juday Discusses Uptake Challenges in CBT for Insomnia

November 11th 2021, 4:30pm

Video

Theresa Juday, RPh, director, Specialty Product Development, CVS Health, speaks about the barriers affecting uptake of cognitive behavioral therapy (CBT) as a first-line treatment for insomnia.

Antidepressant Use Linked With Impaired REM Sleep, Quality of Life

November 8th 2021, 6:00pm

Article

Findings of an abstract presented at CHEST 2021 indicated that antidepressant use was associated with increased REM sleep latency and a complete lack of REM sleep, which may contribute to the poorer quality-of-life scores observed in these patients.

Dr Daniel Greer Discusses At-Risk Populations, Comorbidities of Chronic Insomnia

November 5th 2021, 3:00pm

Video

Daniel Greer, PharmD, BCPP, clinical assistant professor, Rutgers Ernest Mario School of Pharmacy, speaks on at-risk populations of chronic insomnia, and the reciprocal relationship between the condition and other comorbidities.

Sleep-Disordered Breathing in Early Pregnancy Linked With Insulin Resistance, Gestational Diabetes Risk

November 2nd 2021, 5:00pm

Article

An abstract presented at CHEST 2021 showed that women who entered pregnancy with sleep-disordered breathing were associated with higher levels of insulin resistance and potential risk of gestational diabetes.

Long-term Adherence to CPAP May Reduce Blood Pressure in Patients With OSA

October 29th 2021, 4:00pm

Article

Patients with obstructive sleep apnea with adequate continuous positive airway pressure (CPAP) therapy adherence exhibited significant reductions in diastolic blood pressure long term, compared with counterparts with poor adherence.

CVS Health's Theresa Juday on Payer Investment in CBT for Insomnia

October 28th 2021, 1:00pm

Video

Theresa Juday, RPh, director, Specialty Product Development, CVS Health, discusses how payer interest in the use of cognitive behavioral therapy for insomnia has grown in recent years.